134
Views
9
CrossRef citations to date
0
Altmetric
Review

mTOR-blocking agents in advanced renal cancer: an emerging therapeutic option

, &
Pages 175-187 | Published online: 21 Jan 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Bruno Bockorny & Constantin A Dasanu. (2013) Intrinsic immune alterations in renal cell carcinoma and emerging immunotherapeutic approaches. Expert Opinion on Biological Therapy 13:6, pages 911-925.
Read now
Constantin A Dasanu, Shounak Majumder, Srila Gopal, Elena Stoica-Mustafa & Guru Trikudanathan. (2012) Emerging therapeutic options for advanced enteropancreatic neuroendocrine tumors. Expert Opinion on Pharmacotherapy 13:4, pages 461-471.
Read now
Mark R Lackner. (2010) Prospects for personalized medicine with inhibitors targeting the RAS and PI3K pathways. Expert Review of Molecular Diagnostics 10:1, pages 75-87.
Read now

Articles from other publishers (6)

QI CHEN, BIN CAO, NING NAN, YU WANG, XU ZHAI, YOUFANG LI & TIE CHONG. (2016) TPX2 in human clear cell renal carcinoma: Expression, function and prognostic significance. Oncology Letters 11:5, pages 3515-3521.
Crossref
Zhi-Jun Dai, Jie Gao, Xiao-Bin Ma, Hua-Feng Kang, Bao-Feng Wang, Wang-Feng Lu, Shuai Lin, Xi-Jing Wang & Wen-Ying Wu. (2012) Antitumor Effects of Rapamycin in Pancreatic Cancer Cells by Inducing Apoptosis and Autophagy. International Journal of Molecular Sciences 14:1, pages 273-285.
Crossref
Rongrui Li, Riguang Wang, Raosheng Zhai & Zhen Dong. (2018) Targeted Inhibition of Mammalian Target of Rapamycin (mTOR) Signaling Pathway Inhibits Proliferation and Induces Apoptosis of Laryngeal Carcinoma Cells in vitro. Tumori Journal 97:6, pages 781-786.
Crossref
Didier Roulin, Nicolas Demartines & Olivier Dormond. (2011) ATP-competitive inhibitors of mTOR: new perspectives in the treatment of renal cell carcinoma. Biochemical Society Transactions 39:2, pages 492-494.
Crossref
Nicole A. Johnson, Bing-Hung Chen, Shian-Ying Sung, Chia-Hui Liao, Wan-Chi Hsiao, Leland W. K. Chung & Chia-Ling Hsieh. (2010) A novel targeting modality for renal cell carcinoma: human osteocalcin promoter-mediated gene therapy synergistically induced by vitamin C and vitamin D3. The Journal of Gene Medicine 12:11, pages 892-903.
Crossref
Donald J. AbrahamWilliam J. Pitts. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 983 1063 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.